Pre‐treatment neutrophil‐to‐lymphocyte ratio is an independent prognostic factor in head and neck squamous cell carcinoma: Meta‐analysis and trial sequential analysis-Reference-Cited by-同舟云学术

Pre‐treatment neutrophil‐to‐lymphocyte ratio is an independent prognostic factor in head and neck squamous cell carcinoma: Meta‐analysis and trial sequential analysis

Published:2021-12-09 Issue:1 Volume:51 Page:39-51
ISSN:0904-2512
Container-title:Journal of Oral Pathology & Medicine
language:en
Short-container-title:J Oral Pathology Medicine

Author:

Mariani Pierluigi¹,Russo Diana¹,Maisto Marco¹,Troiano Giuseppe²^ORCID,Caponio Vito Carlo Alberto²,Annunziata Marco¹,Laino Luigi¹

Affiliation:

1. Multidisciplinary Department of Medical‐Surgical and Odontostomatological Specialties University of Campania "Luigi Vanvitelli" Naples Italy

2. Department of Clinical and Experimental Medicine University of Foggia Foggia Italy

Publisher

Wiley

Subject

Periodontics,Cancer Research,Otorhinolaryngology,Oral Surgery,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jop.13264

Reference62 articles.

1. Head and neck squamous cell carcinoma;Johnson DE;Nat Rev Dis Prim,2020

2. Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011;Braakhuis BJM;Oral Oncol,2014

3. Hallmarks of cancer: the next generation;Hanahan D;Cell,2011

4. Inverse role of distinct subsets and distribution of macrophage in lung cancer prognosis: a meta‐analysis;Wu P;Oncotarget,2016

5. Tumor‐associated neutrophils as a new prognostic factor in cancer: a systematic review and meta‐analysis;Shen M;PLoS One,2014

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What prognostic factors have impacted the efficacy of immune checkpoint inhibitors in patients with recurrent or metastatic oral cancer?;Journal of Stomatology, Oral and Maxillofacial Surgery;2024-09

2. From Tumor Macroenvironment to Tumor Microenvironment: The Prognostic Role of the Immune System in Oral and Lung Squamous Cell Carcinoma;Cancers;2024-08-03

3. A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer;Vaccines;2024-04-29

4. MicroRNA expression as a prognostic biomarker of tongue squamous cell carcinoma (TSCC): a systematic review and meta-analysis;BMC Oral Health;2024-03-31

5. The Neutrophil-to-Lymphocyte Ratio as a Biomarker in Cutaneous Oncology: A Systematic Review of Evidence beyond Malignant Melanoma;Cancers;2024-03-04